Ebika by’Empeke z’Okuggyamu Embuto n’Ebika Ebyesigika Mu nsi yonna
Mifepristone ne misoprostol zombi mpeke z'okugyamu embuto era zisobola okusangibwa munsi yona mu nsabbika ez`enjawulo. Tusubira endagiriro eno ku bika by’empeke eby’enjawulo ejjakukuyamba okutegera byonna byewetaga okumanya. Bw`oba olina ebibuzo ebisukako wano, kwatagana ne ba kansala baffe nga oyita ku emailo oba okunyumyamu nabo era tujja kubera basanyufu okukuyamba.
EMPEKE Z'OKUGGYAMU EMBUTO
Bika ki eby’enjawulo eby’empeke ez’okuggyamu embuto era zikola zitya?
Empeke z'okuggyamu embuto zirina ebika bibiri era nga buli emu erina enkola ya njawulo. Mifepristone eziyiza obusimu obwetaagisa olubuto okukula, ate misoprostol ekola nga egonza n,okuggulawo omumwa gwa nnabaana (omumwa gwa nnabaana) , ekiletera nnabaana okukonzibwa ekivako olubuto okuvaamu. Byombi Mifeprestone ne Misoprostol oba Misoprostol yeeka bikola bulungi. Naye Mifeprostone nga agatidwa ne Misoprostone bikola bulungi nnyo, singa sente zibawo wamu nekukatale. Wabula bwe kiba nga weziri era nga si kya bbeeyi, empeke ezigatta mifepristone ne misoprostol zikola bulungi. Empeke z’okuggyamu embuto zirina ebika bingi eby’enjawulo ku katale. Okubeerawo kwazo emirundi mingi kisinziira ku kifo w’obeera.
OMUTINDO GW'EMPEKE N'EBITEESO
Ebika Byonna Eby'mpeke Z’okuggyamu Embuto Bikola Mu ngeri Y’emu?
Ebimu ku bika by'empeke z'okuggyamu embuto bijja nga pakati ezigatta nga mulimu mifepristone ne misoprostol, ate ebirala biwa eddagala lino okwawukana. safe2choose erina ebiragiro ebikwata ku ngeri y'okukozesaamu empeke z'okuggyamu embuto mu ngeri ey'obukuumi, nga bikwata ku nkola zombi ezigatta n'okukozesa misoprostol yokka. Okunoonyereza okwakakolebwa kwalaga nti ebitundu nga 10% byokka ku bika bya misoprostol ne 25% byokka ku pakati ezigatta mu nsi 44 bye bituukana n’omutindo gw’ensi yonna, gamba nga okukkiriza nga kusinzira ku Ebisaanyizo bya WHO (WHO‐PQ) oba Ekitongole ekikakali ekivunaanyizibwa ku kulungamya (SRA). Kino kitegeeza nti wadde empeke nnyingi ziwandiisiddwa, okufuna eddagala eryesigika era erikola obulungi kiyinza okuba ekizibu. Ebika bya misoprostol ebimu biyinza obutaba na kirungo kituufu oba okufiirwa amaanyi singa tebiterekebwa bulungi. Ebika ebikkirizibwa abalungamya abeesigika, nga Medabon, Mariprist, oba Mifegyne, ebiseera ebisinga biba bya mutindo mulungi, ogukwatagana.
Okutwalira awamu mifepristone esinga okubeera ennywevu, naye misoprostol ekwatibwa ebbugumu n’obunnyogovu, ekiyinza okukosa engeri gy’akola obulungi. Y’ensonga lwaki kikulu okufuna empeke okuva mu bifo ebyesigika n’ozitereka mu bipapula byazo ebyasooka ebissiddwako akabonero, wala n’obunnyogovu. Noonyereza ebisingawo ku empeke z'okuggyamu embuto erisangibwa mu nsi yo oba engeri y’okuzuulamu empeke z’okuggyamu embuto ku yintaneeti ne ku yintaneeti. Osobola okutuukirira ttiimu yaffe okufuna obuwagizi obulala buli lw'oba weetaaga, tuli wano ku lulwo!
EBIIKA BY.EMPEKE Z'OKUGGYAMU EMBUTO
Ebika by’empeke z’okuggyamu embuto bili bimmeka mu nsi yonna?
Waliwo ebika by’empeke ez’enjawulo ezisoba mu 78 ez’okuggyamu embuto mu nsi yonna. Obuganzi bw’empeke z’okuggyamu embuto businziira ku kitundu. Okugeza, Cytotec kye kiika esinga okwettanirwa mu nsi yonna. Wabula Unwanted-Kit kye kiika esinga okwettanirwa mu Buyindi. Wano waliwo ebiragiro ebikwata ku bubonero bw’empeke z’okuggyamu embuto ezisinga okwettanirwa wammanga:
Okubeerawo kw'Empeke Mubuli Kitundu
Ekitongole ky'ebyobulamu mu nsi yonna (WHO) kiwandiika byombi mifepristone ne misoprostol ng'eddagala eryetaagisa [7] kubanga teririna bulabe era likola bulungi okumalawo olubuto.
Okufuna eddagala lino kulongooseddwa mu myaka kkumi egiyise, naye wakyaliwo ebituli ebinene. Okwekenenya okwakakolebwa mu nsi 44 ezirina ssente entono n’eza wakati [10] kwazuula nti ebintu ebikozesebwa misoprostol byokka bifunibwa nnyo, ate nga mifepristone ne combi‐packs (ekibokisi ekirimu eddagala lyombi mu bungi obutuufu) kizibu okusanga. Omutindo kye kisinga okweraliikiriza. Ne bwe wabaawo empeke z’okuggyamu embuto, obutale obutongole n’obutali butongole tebukakasa nti ddagala eritali lya bulabe era eryesigika. Kino kiteeka obulamu bw’abantu mu matigga. Emiwendo gy’empeke z’okuggyamu embuto nagyo gyawukana nnyo okusinziira ku kitundu. Mu Latin Amerika ne Afrika, emiwendo gitera okuba waggulu, era kiyinza okuba ekizibu okufuna empeke ez’omutindo. Mu nsi ezirina amateeka amakakali agakwata ku kuggyamu embuto, abantu bangi beesigamye ku butale obutali butongole ng’empeke ziyinza okuba ez’ebbeeyi ate oluusi n’ebicupuli. Okwawukanako n'ekyo, mu Asia naddala mu nsi nga Buyindi, okutwalira awamu empeke z'okuggyamu embuto za bbeeyi era zeesigika.
Empeke z'okuggyamu embuto mu Afrika
Mu Afrika, misoprostol y’empeke esinga okusangibwa mu kuggyamu embuto, etera okutundibwa wansi w’ebika ebiwerako mu butale obutongole n’obutali butongole. Pakati eziwandiisiddwa ezigatta ne mifepristone zisangibwa mu nsi ezimu naye nga tezitera kubeerawo era tezisaasaanyizibwa mu ngeri etategeerekeka.
Okubeerawo kw'Ebiika Mu nsi Yonna
Ebika bya Misoprostol
| Cytotec (Pfizer) | Armenia, Australia, Austria, Azerbaijan, Bahrain, Belgium, Belize, Benin, Bolivia, Burkina Faso, Cambodia, Cameroon, China, Côte d'Ivoire, Dem. Rep. of Congo, Dominican Republic, Ecuador, El Salvador, Finland, Gabon, Georgia, Ghana, Greece, Guatemala, Guinea, Guyana, Iceland, Indonesia, Ireland, Italy, Kenya, Kyrgyzstan, Lebanon, Lithuania, Luxembourg, Mexico, Morocco, Myanmar, Netherlands, Nigeria, Norway, Peru, Poland, Portugal, Saudi Arabia, Spain, Sweden, Switzerland, Thailand, Togo, Turkey, Uganda, United Kingdom, United States, Uzbekistan, Zambia |
| Miso‑Fem | Bolivia, Cameroon, Côte d'Ivoire, Ecuador, Ethiopia, Ghana, Laos, Liberia, Senegal, Sierra Leone |
| Misoclear | Burkina Faso, Cambodia, Cameroon, Côte d'Ivoire, Ghana, Kenya, Liberia, Madagascar, Malawi, Mali, Myanmar, Niger, Nigeria, Senegal, Sierra Leone, Tanzania, Uganda, Zambia, Zimbabwe |
| Miso‑Kare | India, Kenya, South Sudan, Tanzania, Uganda |
| Avertiso | Benin, Botswana, Cameroon, Mali, Namibia, Nigeria, Uganda, Zimbabwe |
| Taneciprol | Republika ya Dominican, El Salvador, Guatemala, Honduras, Mexico |
| Misoprostol (Naari) | Chile, Kenya, Myanmar, Nigeria, Peru, Tanzania, South Sudan |
| Prostokos | Brazil |
| Misotrol | Chile and Latin Amerika |
| Misofar | Albania, Angola, Republika ya Congo, Côte d’Ivoire, Dominican Republic, El Salvador, Guinea, Honduras, Lebanon, Madagascar, Mali, Mauritania, Moldova, Mozambique, Spain |
| Oxaprost® | Argentina |
Ezigattidwa awamu ( mifepristone ne misoprostol):
| Unwanted- Kit (Mankind Pharma) | Ebuyindi | |
| MA Kare | Uganda, Kenya | |
| Medabon (Sun Pharma): | Argentina, Barbados, Belarus, Belize, Benin, Bolivia, Burkina Faso, Cambodia, Ethiopia, Ghana, Kazakhstan, Kenya, Kyrgyzstan, Laos, Moldova, Mozambique, Makedoni ey’obukiikakkono, Romania, South Afrika, Sudan, Thailand, Tunisia, Bungereza, Vietnam, Zambia | |
| China Zizhu co‑pack: | Burkina Faso, Guinea-Bissau, Mozambique, São Tomé and Príncipe, Zimbabwe | |
| Divabo | Cambodia, Uganda, Zambia | |
| Mariprist | Burkina Faso, Cambodia, Côte d'Ivoire, Ghana, Kenya, Liberia, Sierra Leone, Uganda, Uruguay, Zambia, Zimbabwe |
Mifepristone etundibwa yokka
| Mediprist | Uganda |
| Mifepristone LinePharma | Bolivia, Colombia |
| Mifetril | Uganda |
| Mifegest | Ebuyindi |
Oyagala amawulire ku bika ebiri mu nsi yo? Kyalira MedAb.org okumanya ebisingawo ebikwata ku nsi oba tuukirira bankasala baffe.
Tuukirira n'Obuwagizi
Funa obuyambi n’okubudaabudibwa ku kuggyamu embuto
Tuwa amawulire agesigamiziddwa ku bujulizi ku kuggyamu embuto mu ngeri etali ya bulabe. Empeereza yaffe ey'okubudaabuda ey'obwereere terina bulabe, ya kyama, nnyangu, era terimu kusalawo. Tulinze obubaka bwo.
Gyebiva n'obukugu bwabasawo obuli emabegga wabuno obubaka
Bya timu ya safe2choose era nabawagizi abakugu ku carafem, okusinzilla ku kulungamya kw'okufayo kukujjamu embuto kwa WHO 2022; epipya ku ddwaliro mu byobulamu 2023 bya Ipas ne ebilungamya ku bya malwaliro ku fayo eri okujjamu embuto bya NAF.
safe2choose eyambibwa Olukiiko Oluwabula ku by’Obujjanjab eyakolebwa abakugu mu by'obulamu ebyokwegata(SRHR)
carafem ewa okufayo okwedembe n'obukugu nga ojjemu olubuto era entegeka ya maka abantu basobole fuga owudendo n'okuwa abaana babwe amabanga.
Ipas kitongole kya nsiyona ekyesigamye kuku gaziya okufuna okujjamu embuto okutali kwabulabe ne okufayo eri okulwanisa embuto.
WHO – ekitongole ky’ebyobulamu mu nsi yonna – kitongole kya njawulo mu kibiina ky’Amawanga Amagatte ekivunaanyizibwa ku by’obulamu by’ensi yonna.
NAF – ye Ekitongole eky'gwanga Ekyokugyamu Embuto - ekitongole ekyabakugu mu USA ekiyamba kujjamu embuto okutalikwabulabe, okwekakasibwa ne dembe lyobulamu.
[1] "Abortion care guideline." World Health Organization, 2022, srhr.org/abortioncare/.
[2] Jackson, E. "Clinical Updates in Reproductive Health." Ipas, 2023, www.ipas.org/wp-content/uploads/2023/09/Ipas-Clinical-Updates-in-Reproductive-Health-CURHE23b.pdf.
[3]"Clinical Policy Guidelines." National Abortion Federation, 2024, prochoice.org/providers/quality-standards/.
[4] Platais, I., et al. "Prospective study of home use of mifepristone and misoprostol for medical abortion up to 10 weeks of pregnancy in Kazakhstan." International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2016;134(3): 268–271, www.ncbi.nlm.nih.gov/pubmed/?term=Prospective+study+of+home+use+of+mifepristone+and+misoprostol+for+medical+abortion+up+to+10+weeks+of+pregnancy+in+Kazakhstan. Accessed May 2025.
[5] Raymond, E. G., Harrison, M. S., & Weaver, M. A. ""Efficacy of Misoprostol Alone for First-Trimester Medical Abortion: A Systematic Review."" Gynuity Health Projects, 2019, gynuity.org/resources/efficacy-of-misoprostol-alone-for-first-trimester-medical-abortion-a-systematic-review. Accessed May 2025.
[6] Consorcio Latinoamericano Contra el Aborto Inseguro (CLACAI). Mifepristona y misoprostol en seis países de América Latina: procesos de registro y disponibilidad. Enero 2017, Lima, Perú. Retrieved from: https://clacaidigital.info/bitstream/handle/123456789/1000/Mifepristona%20y%20misoprostol%20en%20seis%20paises%20de%20America%20Latina.%20CLACAI%202017.pdf?sequence=1&isAllowed=y
[7] WHO Expert Committee on Selection and Use of Essential Medicines. The Selection and Use of Essential Medicines 2023: Executive Summary of the Report of the 24th WHO Expert Committee on Selection and Use of Essential Medicines. World Health Organization, 2023, who.int/publications/i/item/WHO-MHP-HPS-EML-2023.01 Accessed Aug. 2025.
[8] Sedgh, G., & Taqi, I. Mifepristone for Abortion in a Global Context: Safe, Effective and Approved in Nearly 100 Countries. Guttmacher Institute, 2023, guttmacher.org/2023/07/mifepristone-abortion-global-context-safe-effective-and-approved-nearly-100-countries. Accessed Aug. 2025.
[9] MedAb.org. Research and Analysis. MedAb, n.d., medab.org/research-analysis. Accessed Aug. 2025.
[10] Durocher, J., Kilfedder, C., Frye, L. J., Winikoff, B., & Srinivasan, K. A Descriptive Analysis of Medical Abortion Commodity Availability and Pricing at Retail Outlets in 44 Countries Across Four Regions Globally. Taylor & Francis Online, 2021, tandfonline.com/doi/full/10.1080/26410397.2021.1982460. Accessed Aug. 2025.
[11] IPPF (International Planned Parenthood Federation). Abortion Commodities Database. IPPF Medical Abortion Commodities Database, n.d., medab.org/search. Accessed Aug. 2025.